The National Comprehensive Cancer Network (NCCN) Oncology Researc...
Optum, a leading health services company, completed its acquisition of...
Three quarters of people living with epilepsy in low-income countries ...
Edesa Biotech, a clinical-stage biopharmaceutical company has rep...
Verastem, a biopharmaceutical company focused on developing...
Genocea Biosciences, a biopharmaceutical company developing perso...
A team of researchers from Carnegie Mellon University, in collabo...
CyTuVax B.V.has released the results of the HBAI20 Phase 2 “BE-R...
Be The Match BioTherapies®, an organization offering solutions for...
Imcyse, a developer of active specific immunotherapies for the treatme...
WHO has launched a global campaign urging governments to adopt a tool ...
Varian has acquired Endocare® Systems, based in Austin, Texas...
Pfizer Inc. has announced positive results from ORAL Shift, a Phase 3b...
Pfizer Inc. and Array BioPharma Inc. have announced that they have ent...
GlaxoSmithKline plc has announced a five-year collaboration with the U...
Using sound vibrations and pulses of near-infrared light, a Rutgers Un...
Long-term follow-up data from the ongoing, pivotal open-label ENESTfre...
BlackThorn Therapeutics, a clinical-stage, neurobehavioral health comp...
